Tag:

Synflorix

Latest Headlines

Latest Headlines

GSK, Pfizer commit more vaccines to Unicef program

The early success of a Unicef program to bring pneumococcal vaccines to poor countries has created a problem for the agency--demand is outstripping supply. To fix the problem, Unicef has negotiated new deals with GlaxoSmithKline and Pfizer, securing more vaccines at lower costs.

GSK's Synflorix gleans positive results in infants

Results from the first randomized controlled European clinical trial of GlaxoSmithKline's ($GSK) pneumococcal conjugate vaccine show it's highly effective when it comes to preventing invasive pneumococcal disease in infants younger than age 2.

20 Top-selling Vaccines-- H1 2012

As H1 came to a close, FierceVaccines decided to take a look at which prophylactic vaccines flew off the shelves--and which companies made the sales.

The 20 top-selling vaccines in H1 2012

As H1 came to a close, FierceVaccines decided to take a look at which prophylactic vaccines flew off the shelves--and which companies made the sales. Take a look at the full list >>

Argentina fines GSK $93K for Synflorix vaccine trial

Argentina's government has fined GlaxoSmithKline ($GSK) $93,000 for its management of trials of the vaccine Synflorix in which 14 babies died. This case brings to light questions as to how big...

Pfizer and GSK boost pneumonia vaccine price cuts for developing world

Just in time for the holiday season, Pfizer ($PFE) and GlaxoSmithKline ($GSK) said they are selling an additional 360 million doses of their pneumonia vaccine to a global health organization at a

Vaccine gives dangerous pneumococcus strains an opening

When a vaccine that guards against the most common causes of pneumococcal disease comes to the market, it's simultaneously creating fresh opportunities for strains not covered in the shot, scientists

GSK under fire for delay of new vax program

GlaxoSmithKline made a splash in the media several months ago when it joined with Pfizer and announced that it would supply 30 million doses of vaccine each year to protect children in developing

GSK, Pfizer discount vaccines for poor

Over the next 10 years, kids in developing countries will see a stream of discounted vaccines from Pfizer and GlaxoSmithKline. The two drugmakers have inked a long-term vaccine deal with the GAVI

GSK gets bad press in U.S., Argentina

Families in Argentina are saying GlaxoSmithKline tricked them into participating in an experimental vaccine trial by telling them their children were receiving medical treatment, according to an ABC